Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease
Publication date
2025-11
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Immunology and Allergy, Rheumatology, Immunology
Citation
Rijnenberg, D, Hamkour, S, Redegeld, F, Leavis, H & van Roon, J 2025, 'Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease', The Lancet. Rheumatology, vol. 7, no. 11, pp. e754-e756. https://doi.org/10.1016/S2665-9913(25)00219-X